drugset / Trial / NCT00048360
Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a placebo controlled study evaluating the efficacy and safety of medication in adults with Attention-Deficit Hyperactivity Disorder (ADHD).
Timeline
- Start
- 2002-10
- Primary completion
- 2003-06
- Completion
- 2003-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 300 mg | — |
| Subject | Bupropion | Small molecule | 450 mg | — |